Effects of CYP2C19 and MDR1 Genotype On the Eradication Rate of Helicobacter pylori Infection By PPI Based Triple Therapy

被引：0
|
作者：
Oh, Jung Hwan
Choi, Myung-Gyu
Dong, Mi Sook
Cho, Yu Kyung
Park, Jae Myung
Jeong, Jeong Jo
Lee, In Seok
Kim, Sang Woo
Chung, In-sik
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A342 / A342
页数：1
相关论文
共 50 条
  • [31] Reliable Efficacy of 14-Day High Dose PPI Triple Therapy for Helicobacter pylori Eradication Independent Effect of CYP2C19 Genotype and High Prevalence of Metronidazole Resistance in Thailand
    Vilaichone, Ratha-korn
    Prasertpetmanee, Sanchai
    Mahachai, Varocha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S46 - S46
  • [32] The effect of rabeprazole and orneprazole-based triple therapy on eradication of Helicobacter pylori and its correlation to Cyp2C19 genetic polymorphisms
    Li, YY
    Wang, H
    Jiang, YJ
    Nie, YQ
    GASTROENTEROLOGY, 2005, 128 (04) : A431 - A431
  • [33] RELIABLE EFFICACY OF 14-DAY HIGH DOSE PPI TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION INDEPENDENT EFFECT OF CYP2C19 GENOTYPE AND HIGH PREVALENCE OF METRONIDAZOLE RESISTANCE IN THAILAND
    Prasertpetmanee, S.
    Mahachai, V.
    Vilaichone, R.
    HELICOBACTER, 2012, 17 : 99 - 99
  • [34] The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication
    Kim, Mi Na
    Kim, Nayoung
    Lee, Sang Hyup
    Park, Young Soo
    Hwang, Jin-Hyeok
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Lee, Dong Ho
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    HELICOBACTER, 2008, 13 (04) : 261 - 268
  • [35] Influences of CYP2C19, MDR, IL1-β on H. pylori eradication
    Mahachai, V.
    Vilaichone, R-K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 28 - 28
  • [36] CYP2C19 genotype status and dual therapy with omeprazole and amoxicillin for eradication of Helicobacter pylori and peptic ulcer healing.
    Furuta, T
    Ohashi, K
    Kamata, T
    Takashima, M
    Hanai, H
    Kosuge, K
    Kubota, T
    Ishizaki, T
    Kaneko, E
    GASTROENTEROLOGY, 1998, 114 (04) : A127 - A127
  • [37] CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication
    Lin, Tsung-Jung
    Lee, Hsi-Chang
    Lin, Chih-Lin
    Wang, Chung-Kwe
    Chen, Kuan-Yang
    Wu, Deng-Chyang
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (12) : 514 - 520
  • [38] CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication
    Tsung-Jung Lin
    Hsi-Chang Lee
    Chih-Lin Lin
    Chung-Kwe Wang
    Kuan-Yang Chen
    Deng-Chyang Wu
    World Journal of Clinical Cases, 2018, 6 (12) : 514 - 520
  • [39] Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism
    Sheu, BS
    Kao, AW
    Cheng, HC
    Hunag, SF
    Chen, TW
    Lu, CC
    Wu, JJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (03) : 283 - 288
  • [40] Usefulness of combination assay of Cyp2c19 and Mdr1 polymorphisms in dual therapy with proton pump inhibitor and amoxicillin for eradication of H-pylori
    Kodaira, Chise
    Sugimoto, Mitsushige
    Nishino, Masafumi
    Shirai, Naohito
    Ikuma, Mutsuhiro
    Hishida, Akira
    Furuta, Takahisa
    GASTROENTEROLOGY, 2007, 132 (04) : A611 - A611
12345